2025. Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity. Journal of Carcinogenesis. 24, 3s (Oct. 2025), 812–830. DOI:https://doi.org/10.64149/J.Carcinog.24.3s.812-830.